DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 31 · September 1998 DOI: 10.1055/s-002-6319

Original Paper

  • 159
    Broich, K.; Grünwald, F.; Kasper, S.; Klemm, E.; Biersack, H.-J.; Möller, H.-J.:

    D2-Dopamine Receptor Occupancy measured by IBZM-SPECT in Relation to Extrapyramidal Side Effects

  • 163
    Ulrich, S.; Neuhof, S.; Braun, V.; Meyer, F. P.:

    Therapeutic Window of Serum Haloperidol Concentration in Acute Schizophrenia and Schizoaffective Disorder

  • 170
    Möller, H.-J.; Gallinat, J.; Hegerl, U.; Arató, M.; Janka, Z.; Pflug, B.; Bauer, H.:

    Double-Blind, Multicenter Comparative Study of Sertraline and Amitriptyline in Hospitalized Patients with Major Depression

  • 178
    Wancata, J.; Benda, N.; Lesch, O.; Müller, C.:

    Use of Anxiolytics and Hypnotics in Gynecological, Surgical and Medical Departments of General Hospitals

  • 187
    Uebelhack, R.; Franke, L.; Schewe, H.-J.:

    Inhibition of Platelet MAO-B by Kava Pyrone-Enriched Extract from Piper Methysticum Forster (Kava-Kava)

  • 193
    Krieger, K.; Klimke, A.; Henning, U.:

    Active [3H]-Dopamine Uptake Displayed by Native Lymphocyte Suspensions is Mainly Due to Contaminating Platelets

    • Short Communication

  • 199
    Härtter, S.; Wetzel, H.; Hammes, Elke; Torkzadeh, M.; Hiemke, C.:

    Serum Concentrations of Fluvoxamine and Clinical Effects: A prospective open clinical trial

  • 201
    Normann, C.; Brandt, C.; Berger, M.; Walden, J.:

    Delirium and Persistent Dyskinesia Induced by a Lithium-Neuroleptic Interaction